Klaudija Marijanovic Barac | EU QPPV Deputy, Associate VP
Eli Lilly and Company

Klaudija Marijanovic Barac is a pharmacovigilance physician with over two decades of drug safety leadership in the pharmaceutical industry, building deep expertise across EU GVP requirements, risk management, and health authority interactions. As EU QPPV Deputy at Eli Lilly and Company, she leads PV oversight and compliance for a dedicated therapeutic area portfolio, with insight across the wider product range. A former Co-Chair of the PV Working Group at Medicines for Europe and an active member of the EFPIA PVEG, Klaudija continues to advance patient-centered safety standards across the EU.